NAGE

NIAGEN BIOSCIENCE INC

NAGE·171077407·US·Common Stock·Healthcare - Biotechnology-13D/G

NAGE (NIAGEN BIOSCIENCE INC) is held by 91 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($13.3M), VANGUARD CAPITAL MANAGEMENT LLC ($6.8M), Qube Research & Technologies Ltd ($5.2M). Net institutional sentiment: Mixed.

91
Holders
(7 Elite)
$82M
Total Value
47% (96)
Consensus
45 buying - 51 selling
13F: Insider & Congress: Updated regularly
NAGE

Smart Money Verdict

View all
Loading verdict
Held by 91 funds
7 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Apr 27, 2026 · Activists Jul 29, 2026 · Congress none

ActivistBlackRock, Inc.BlackRock, Inc.5.2%Jul 29, 2026
InsiderFNFried Robert NExercise 20K shApr 24, 2026
ActivistThe Vanguard GroupThe Vanguard Group4.1%Jan 30, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
4.2M(+8.1%)$13.3M0.0%-44.10%
30
Decreased
2.1M(-0.1%)$6.8M0.0%-32.24%
0
Decreased
1.6M(-5.2%)$5.2M0.0%-46.19%
0
Increased
1.5M(+9.9%)$4.7M0.0%-28.49%
30
Decreased
1.3M(-8.7%)$4.1M0.0%-64.23%
0
Increased
1.3M(+0.9%)$4M0.0%-49.45%
27
Decreased
1.2M(-50.8%)$3.7M0.0%-49.05%
0
Decreased
1.2M(-4.5%)$3.7M0.0%-32.24%
0
Decreased
1.1M(-0.2%)$3.5M0.0%-31.27%
0
Decreased
659,584(-50.4%)$2.1M0.0%-39.72%
0
Increased
630,109(+18.8%)$2M0.0%-50.65%
30
Decreased
605,326(-43.5%)$1.9M0.0%-60.74%
0
Increased
504,772(+32.5%)$1.6M0.0%-54.86%
33
Increased
473,372(+11.3%)$1.5M0.0%-60.12%
28
Decreased
472,056(-54.2%)$1.5M0.0%-54.28%
0
Decreased
471,934(-51.4%)$1.5M0.0%-42.63%
0
Increased
466,720(+17.8%)$1.5M0.0%-25.46%
30
Decreased
458,614(-21.3%)$1.5M0.0%-44.58%
0
Decreased
431,614(-3.5%)$1.4M0.0%-60.10%
0
Increased
400,253(+6.9%)$1.3M0.0%-30.69%
27

Showing 1-20 of 103

1 / 6
NAGENAGENIAGEN BIOSCIENCE INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used